An Act To Encourage the Proper Disposal of Expired Pharmaceuticals
Maine Legislature, Session 121, LD 1826
Committee Amendment CA_A-SA_B_S572 (Senate)

SENATE 
AMENDMENT "..B" to COMMITTEE 
AMENDMENT 
"A" to S . P . 
671, L.D. 1826, Bill, "An Act To Encourage the Proper Disposal of 
Expired Pharmaceuticals" 
Amend the amendment by striking out all of sections 2 and 3 
and inserting in their place the following: 
'Sec. 2. Maine Drug Return Implementation Group. 
The Director 
of the Maine Drug Enforcement Agency wi thin the Department of 
Public Safety shall establish and convene the Maine Drug Return 
Implementation 
Group, 
referred 
to 
in 
this 
section 
as 
"the 
implementation group," to assist the agency on implementation 
issues 
for 
the 
Unused 
Pharmaceutical 
Disposal 
Program, 
established in the Maine Revised Statutes, Title 22, chapter 604, 
referred to in this section as "the program." 
1. 
Issues. 
The 
implementation 
group 
shall 
study 
the 
following issues and make recommendations for implementation of 
the program in a manner that addresses the issues, safeguards the 
public health and environment and meets 
the requirements of 
local, state and federal law, rule and regulation: 
A. 
Postal regulations; 
B. 
The methods and requirements for packaging, including 
prepaid mailing envelopes; 
C. 
Minimizing drug diversion and theft; 
D. 
Public 
education 
regarding program 
requirements 
and 
operation; and 
Page l-LR2440(10) 
SENATE AMENDMENT 
SENATE AMENDMENT 
" /3" to COMMITTEE 
AMENDMENT 
"A" to S . P • 671, 
L.D. 1826 
E. 
Encouraging the development of drug drop-off programs at 
the local level. 
2. 
Melllbership; 
chair. 
The 
Enforcement Agency shall serve as 
participation on the implementation 
Director of the Maine 
chair and shall invite 
group of the following: 
Drug 
the 
A. 
One 
representative 
of 
local 
municipal 
enforcement 
agencies; 
B. 
One representative of pharmacies; 
C. 
One representative of pharmaceutical manufacturers; 
D. 
One representative of a statewide association of medical 
professionals; 
E. 
The Attorney General or the Attorney General's designee; 
F. 
The Commissioner of Human Services or the commissioner's 
designee; 
G. 
The 
Commissioner of Environmental Protection or the 
commissioner's designee; 
H. 
A representative of the federal Drug Enforcement Agency; 
I. 
A representative of the Office of the United States 
Attorney for the District of Maine: 
J. 
A representative of the United States Postal Service: 
K. 
Interested parties 
and 
interest 
in issues 
related 
pharmaceuticals; and 
persons 
to 
the 
with 
expertise 
and 
disposal 
of 
unused 
L. 
Representatives 
of 
the Joint Standing 
Committee 
on 
Health and Human Services. 
The chair shall call and convene the first meeting no later than 
August 31, 2004. 
3. 
Staffinq. 
provide 
necessary 
implementation group. 
The 
Maine 
Drug 
Enforcement 
Agency 
staffing 
and 
support 
services 
to 
shall 
the 
4. 
Report. 
The Maine Drug Enforcement 
to 
the 
joint 
standing 
committee 
of 
the 
jurisdiction over health and human services 
Agency shall report 
Legislature 
having 
matters by December 
SENATE AMENDMENT 
SENATE AMENDMENT "15,, to COMMITTEE AMENDMENT "A" to s. P. 
671, 
L.D. 1826 
31, 
2004. 
The 
report 
must 
include 
information 
and 
recommendations for implementing the program. 
The joint standing 
committee of the Legislature having jurisdiction over health and 
human services matters shall review the report and may report out 
a bill to the First Regular Session of the l22nd Legislature. 
5. 
Funding. 
The Maine Drug Enforcement Agency may seek 
outside 
funds 
to 
fund 
costs 
of 
the 
implementation 
group. 
Contributions to support the work of the implementation group may 
not be accepted from any party having a pecuniary or other vested 
interest in the outcome of the matters being studied. 
Sec. 3. Effective date. 
That section of this Act that enacts 
the Maine Revised Statutes, Title 22, chapter 604 takes effect 
July 1, 2005. I 
Further amend the amendment by relettering or renumbering 
any 
nonconsecutive 
Part 
letter 
or 
section 
number 
to 
read 
consecutively. 
SUMMARY 
This 
amendment incorporates the effective date provision 
from Senate Amendment "A" to Committee Amendment "A," filing No. 
S-506. 
This amendment makes the following changes: 
1. 
Directs the Director of the Maine 
Drug Enforcement 
Agency within the Department of Public Safety to form the Maine 
Drug 
Return 
Implementation 
Group 
to 
assist 
the 
Maine 
Drug 
Enforcement Agency on issues related to implementation of the 
Unused Pharmaceutical Disposal Program: 
2. 
Describes the membership of the implementation group; 
3. 
Directs the Maine Drug Enforcement Agency to provide 
staff support to the implementation group; 
4. 
outside 
Authorizes 
funds 
for 
implementation group; 
the Maine Drug Enforcement Agency 
costs 
associated with 
the 
work 
to seek 
of 
the 
5. 
Requires the Maine Drug Enforcement Agency to report its 
recommendations 
for 
implementing 
the 
program 
to 
the 
joint 
SENATE AMENDMENT 
SENATE AMENDMENT ':iJ" to COMMITTEE 
AMENDMENT "A" to S.P. 671, 
L.D. 1826 
standing committee of the Legislature having jurisdiction over 
health and human services matters by December 31, 2004; and 
6. 
Strikes the appropriations and allocations section. 
SPONSORED BY: 
(Senator GAGNON) 
COUNTY: 
Kennebec 
FISCAL NOTE REQUIRED 
(See Attached) 
SENATE AMENDMENT 
Appropriationsl Allocations 
Other Special Revenue Funds 
Fiscal Detail and Notes 
Approved: 04128/04 ,;::t;pae 
Office of Fiscal and Program Review 
LD 1826 
An Act To Encourage the Proper Disposal of Expired Pharmaceuticals 
LR 2440(10) 
Fiscal Note for Senate Amendment If)' to Committee Amendment 'A" 
Sponsor: Sen. Gagnon 
Fiscal Note Required: Yes 
Fiscal Note 
Elimination of Legislative Study costs 
2003-04 
$0 
2004-05 
($2,860) 
Projections 
2005-06 
$0 
Projections 
2006-07 
$0 
This amendment strikes the allocation to the Legislature and removes the study. 
LR2440(lO) - Fiscal Note - Page 1 of 1